Gilead chief O'Day recruits top Genentech researcher as new CMO in the wake of a high-level R&D exodus
Gilead CEO Daniel O’Day has found his new chief medical officer in the top ranks of Roche’s storied biotech subsidiary Genentech, where O’Day had a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
